Freiman Paul E. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Freiman Paul E. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Freiman Paul E. is identified as a Director of NovaBay Pharmaceuticals, Inc. in the SEC filings with the most recent filing dated 2026-04-21. Beyond this filing context, no additional public biographical details are provided here.

Board memberships

• NovaBay Pharmaceuticals, Inc.

Awards & honors

• Director of NovaBay Pharmaceuticals, Inc. as of the 2026-04-21 SEC filing

Companies — Last 90 Days

• Stablecoin Development Corp (SDEV) — 1 filings, last 2026-04-21

Frequently Asked Questions

Who is Freiman Paul E.?

Freiman Paul E. is identified as a Director of NovaBay Pharmaceuticals, Inc. in the SEC filings with the most recent filing dated 2026-04-21. Beyond this filing context, no additional public biographical details are provided here.…

How many SEC Form 4 filings has Freiman Paul E. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Freiman Paul E.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week